Stocks and Investing Stocks and Investing
Wed, April 1, 2020

Geoff Meacham Initiated (BTAI) at Strong Buy and Held Target at $45 on, Apr 1st, 2020


Published on 2024-10-27 01:42:51 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $45 on, Apr 1st, 2020.

Geoff has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Geoff's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoff


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $95 on, Wednesday, February 26th, 2020
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Increased Target to $150 on, Friday, February 14th, 2020
Contributing Sources